Evidence map›Paper›PMID 35921044›Full record

ArticleChembiochem : a European journal of chemical biology2022

Tetrazine-Triggered Bioorthogonal Cleavage of trans-Cyclooctene-Caged Phenols Using a Minimal Self-Immolative Linker Strategy.

Patrick Keppel, Barbara Sohr, Walter Kuba, Marion Goldeck, Philipp Skrinjar, Jonathan C T Carlson, Hannes Mikula

Open access · hybridAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Click-Triggered Bioorthogonal Bond-Cleavage Reactions.Topics in current chemistry (Cham) · 2025
    Review
  7. Scission-Enhanced Molecular Imaging (SEMI).Bioconjugate chemistry · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Patrick KeppelInstitute of Applied Synthetic Chemistry, TU Wien, 1060, Vienna, Austria.
Barbara SohrInstitute of Applied Synthetic Chemistry, TU Wien, 1060, Vienna, Austria.
Walter KubaInstitute of Applied Synthetic Chemistry, TU Wien, 1060, Vienna, Austria.
Marion GoldeckInstitute of Applied Synthetic Chemistry, TU Wien, 1060, Vienna, Austria.ORCID 0000-0003-1899-4763
Philipp SkrinjarInstitute of Applied Synthetic Chemistry, TU Wien, 1060, Vienna, Austria.
Jonathan C T CarlsonCenter for Systems Biology & Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.ORCID 0000-0003-4139-9057
Hannes MikulaInstitute of Applied Synthetic Chemistry, TU Wien, 1060, Vienna, Austria.ORCID 0000-0002-9218-9722
TU Wien · ATHarvard University · US

Funding

Austrian Science Fund FWF I 4623
6 · The paper itself

Abstract

Bond-cleavage reactions triggered by bioorthogonal tetrazine ligation have emerged as strategies to chemically control the function of (bio)molecules and achieve activation of prodrugs in living systems. While most of these approaches make use of caged amines, current methods for the release of phenols are limited by unfavorable reaction kinetics or insufficient stability of the Tz-responsive reactants. To address this issue, we have implemented a self-immolative linker that enables the connection of cleavable trans-cyclooctenes (TCO) and phenols via carbamate linkages. Based on detailed investigation of the reaction mechanism with several Tz, revealing up to 96 % elimination after 2 hours, we have developed a TCO-caged prodrug with 750-fold reduced cytotoxicity compared to the parent drug and achieved in situ activation upon Tz/TCO click-to-release.

Indexed as

Heterocyclic CompoundsProdrugsAminesCarbamatesCell Line, TumorCyclooctanesPhenolsAminesCarbamatesCyclooctanesHeterocyclic CompoundsPhenolsProdrugsbioorthogonal chemistryclick chemistrycycloadditioneliminationprodrugs

Identifiers

PMID35921044
PMCPMC9804162
OpenAlexW4289594708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.